Skip to content
Bored Studies
RecruitingAccepts healthy volunteersPhase 1

A Study of IBI3032 in Healthy Participants

Fortvita Biologics (USA)Inc. · NCT07120425

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18–65 · All sexes
Healthy volunteers
Accepted
Study type
Interventional · Phase 1
Target enrollment
32
US sites recruiting
1
Study start
September 10, 2025
Record last updated
September 17, 2025

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

This is a randomized, double-blind, placebo-controlled Phase I clinical study evaluating the safety, tolerability, and PK of a single dose of IBI3032 in healthy participants. This is a single ascending dose (SAD) study. Approximately 32 healthy participants are expected to be enrolled in this study.

The screening period is 4 weeks. Eligible participants will be divided into 4 cohorts. Each cohort consisted of 8 healthy participants who will be randomized in a 6:2 ratio to receive a single dose of IBI3032 or placebo. The safety follow-up period is 15 days. This study is for research purposes only, and is not intended to treat any medical condition.

Being studied: IBI3032; placebo

Conditions: Healthy

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Healthy male or females, as determined by medical history
  • Have safety laboratory results within normal reference ranges

Exclusion Criteria

  • Have known allergies toIBI3032， glucagon-like peptide-1 (GLP-1) analogs, related compounds
  • Abnormal electrocardiogram (ECG) at screening
  • Significant history of or current cardiovascular, respiratory, hepatic, renal, gastrointestinal, endocrine, hematological or neurological disorders.

Recruiting US locations

  • ICON Clinical Research

    Lenexa, KS 66219

    Site contact: Seth Price · 913-205-4397 · Seth.Price@iconplc.com

Study contacts (from the official record)

  • lily Zhang · 13603216253 · lily.zhang@innoventbio.com
All healthy volunteers studies in Kansas →
A Study of IBI3032 in Healthy Participants (NCT07120425) | Bored Studies